Mushroom-derived bioactive components with definite structures in alleviating the pathogenesis of Alzheimer's disease
Alzheimer's disease (AD) is a complicated neurodegenerative condition with two forms: familial and sporadic. The familial presentation is marked by autosomal dominance, typically occurring early in individuals under 65 years of age, while the sporadic presentation is late-onset, occurring in in...
Saved in:
Main Authors: | Xue Jiang (Author), Yu Song (Author), Changshun Lv (Author), Yinghui Li (Author), Xiangru Feng (Author), Hao Zhang (Author), Yujuan Chen (Author), Qingshuang Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medicinal Components in Edible Mushrooms on Diabetes Mellitus Treatment
by: Arpita Das, et al.
Published: (2022) -
The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
by: Song Gao, et al.
Published: (2022) -
The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer's disease
by: Cheong-Meng Chong, et al.
Published: (2019) -
Bioactive Compounds from the Mushroom-Forming Fungus <i>Chlorophyllum molybdites</i>
by: Jing Wu, et al.
Published: (2023) -
Alzheimer's disease - etiology and pathogenesis
by: Grzegorz Wróbel, et al.
Published: (2017)